Over 100 different cannabinoids, that occur naturally in cannabis plants, have been identified and chemically characterized. Delta-9-tetrahydrocannabinol (Δ9-THC), the primary psychoactive compound in Cannabis sativa, has been the subject of extensive scientific investigation since its isolation in the early 1960’s. In its pure form Δ9-THC is a viscous oil, which can make it difficult to handle and measure leading to inaccurate dosing and thus, inconsistent effects.
In attempts to overcome these formulation challenges, multi-component Δ9-THC powders have been created to provide improved handling, dosing accuracies, and health benefits. These new inventions are also protectable through the filing of intellectual property, thus adding additional benefit to the technical improvements. Herein, multiple multi-component Δ9-THC powders have been created, patents (US and PCT) filed, and granted.
See why having our patented products already overcomes common hurdles.
Cannabinoids Themselves Are Not Patentable
Overcoming existing hurdles!
Flowable Δ9-THC Powder Compositions!
“If you aren't sure, always go for Vivlio Book Landing page. It's exactly what I've been looking for. You won't regret it. I don't know what else to say.”
Contact us to learn more or discuss opportunties.
Short description about each chapter. Have any questions? Email Us
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
“I got inspired to completely revamp my eBook online presence. I got tons of knowledge and experience in his kick-ass book, which I finished in one energized breath.”
Not sure if The Perfect sales page is for you? No worries, just download our #free chapter.
If you do all the work and you’re not happy with the outcome then you’ll get your money back. We are confident that you will create a perfect book template after reading our book, but this book is only for serious people, if you don't put in the work or you're not happy we will refund all of the money.
Solid Δ9-Tetrahydrocannabinol (Δ9-THC) Compositions
Adenine
U.S.
11,478,447
07/16/2020
10/25/2022
07/16/2041
Granted
β-nicotinamideadenine dinucleotide + epigallocatechin gallate
U.S.
12,090,137
07/16/2020
09/17/2024
07/16/2041
Granted
β-nicotinamideadenine dinucleotide + saccharin
U.S.
Publication#: 2024/0408049
07/16/2020
---
---
Pending
* Application remains open for future filings which could include combinations of the other powder formers listed:
Caffeine, aspartame, lactose, mannitol, saccharin, nicotinamide, β-nicotinamide adenine dinucleotide (NAD+), epigallocatechin gallate (EGCG), aspartic acid, glutamic acid, glutamine, histidine, leucine, methionine, serine, tryptophan, valine
** Pending PCT applications filed 07/16/2021 in Europe, China, Japan, Canada, India, Australia and Mexico
*** Granted patents have a term of 20 years from the non-provisional filing date
What is claimed for granted patent US11,478,447:
What is claimed for granted patent US12,090,137:
What is claimed for pending patent US2024/0408049:
Steve began his business career with Ernst & Young (“EY”) after receiving his BS, JD, and MBA degrees from Indiana University. Steve served as partner – National Tax Group, Washington, D.C. and led the firm’s national practice in Actuarial, Benefits and Compensation Consulting, New York, NY. He was the CEO of Resorts Condominiums International (“RCI”) which was the world leader in vacation exchange services (2,500,000 members from 165 countries; 3,500 affiliated resorts in 85 countries; 70 offices in 35 countries with 4,500+ employees). He was named Leader of the Year by the American Resort Development Association.
Steve’s passion for business, economic development, and innovation continues with ownership of multiple private companies as well as successful R & D collaborations with Purdue University. In 2020, Steve was conferred the highest honor which the Governor of Indiana bestows – Sagamore of the Wabash. This award is in recognition of his service to the State of Indiana in the areas of entrepreneurship, innovation, and community development.
Nate has over 20 years of experience in the field of solid state chemicals. He has spent his career leading chemical research, inventing (60+ publications and granted patents) and commercializing technologies. Most recently, Nate is active in researching and creating new molecular solid forms of cannabinoids and psychedelics, where he has a strong network of academic and industrial contacts to support his research.
Nate completed his BS, MS and Ph.D. all in Chemistry and then received a prestigious Fulbright postdoctoral fellowship studying at the Louis Pasteur University (Strasbourg, France) under the guidance of a Nobel Laureate. His expertise is in solid-state and supramolecular chemistry, crystal engineering and co-crystals/salts.
.svg){kind=icon}
.jpg){kind=logo}
